Paulash Mohsen - Dec 1, 2021 Form 4 Insider Report for YUMANITY THERAPEUTICS, INC. (KA)

Role
Chief Business Officer
Signature
/s/ Marie Epstein, Attorney-in-Fact
Stock symbol
KA
Transactions as of
Dec 1, 2021
Transactions value $
$0
Form type
4
Date filed
12/3/2021, 03:15 PM
Next filing
Feb 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KA Common Stock Award $0 +20K +48.67% $0.00 61.1K Dec 1, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock award granted under the Yumanity Therapeutics, Inc. Amended and Restated 2018 Stock Option and Grant Plan. Fifty percent of the shares subject to the award will vest six months after the grant date and fifty percent will vest twelve months after the grant date, provided that the award recipient continues to have a service relationship with the Company at such time.